Opdualag

Bristol Myers axes German launch of new cancer drug, citing pricing hurdles
Endpoints
Tue, 03/7/23 - 10:37 pm
Bristol Myers Squibb
Germany
Opdivo
Opdualag
A year of two halves for US approvals
EP Vantage
Thu, 01/19/23 - 09:38 am
FDA
drug approvals
Mounjaro
Eli Lilly
Vabysmo
Roche
Opdualag
Bristol Myers Squibb
Carvykti
JNJ
Vtama
Roivant
Pluvicto
Novartis
What’s next for Bristol Myers' relatlimab?
EP Vantage
Wed, 03/23/22 - 10:36 am
Bristol Myers Squibb
relatilimab
Opdivo
Opdualag
melanoma